Outlook Therapeutics, Inc. OTLK
0.46 USD -0.01 (-1.96%)
At closeNov 4, 2026, 5:02 AM EST
0.48 +0.02 +4.30%
Pre-market · Nov 4, 5:02 AM ET
0.452 Day range 0.4798
0.161 52-week range 2.54
- YTD
- -70.89%
- 1 year
- -64.62%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 24.80 +5291.3% upside
Now 0.46
- Target (low)
- 9.00
- Target (mean)
- 24.80
- Target (high)
- 38.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
- Strong buy1
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.90 | -0.91 – -0.89 | -0.936 | +3.9% | 0 | 0.0% | 2 |
| Next quarter | -0.96 | -0.99 – -0.93 | -0.778 | -23.4% | 0 | 0.0% | 2 |
| Current year | -4.01 | -4.04 – -3.98 | -4.37 | +8.3% | 0 | 0.0% | 2 |
| Next year | -2.63 | -3.01 – -2.24 | -4.01 | +34.5% | 7.63M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2, 2024 | Chardan Capital | Downgrade | Buy | Neutral |
| Nov 29, 2024 | BTIG | Maintained | Buy | Buy |
| Nov 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 16, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 27, 2024 | BTIG | Upgrade | Neutral | Buy |
| Mar 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 15, 2024 | Chardan Capital | Upgrade | Neutral | Buy |
| Jan 25, 2024 | Guggenheim | Upgrade | Neutral | Buy |
| Jan 25, 2024 | Brookline Capital | Upgrade | Hold | Buy |
| Dec 29, 2023 | Ascendiant Capital | Maintained | Buy | Buy |
| Dec 27, 2023 | Capital One | Upgrade | Equal-Weight | Overweight |
| Nov 3, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 31, 2023 | Chardan Capital | Downgrade | Buy | Neutral |
| Aug 31, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 30, 2023 | Brookline Capital | Downgrade | Buy | Hold |
| Aug 30, 2023 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Aug 30, 2023 | BTIG | Downgrade | Buy | Neutral |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Jul 26, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 13, 2023 | Capital One | Initiated | — | Overweight |
| May 16, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| May 16, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 3, 2023 | Guggenheim | Initiated | — | Buy |
| Feb 15, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 6, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jan 6, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 31, 2022 | BTIG | Initiated | — | Buy |